Citadel Advisors’s Moringa Acquisition Corp Class A Ordinary Shares MACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,832
Closed -$140K 15728
2022
Q4
$140K Sell
13,832
-89,739
-87% -$897K ﹤0.01% 10721
2022
Q3
$1.03M Hold
103,571
﹤0.01% 6925
2022
Q2
$1.02M Sell
103,571
-7
-0% -$69 ﹤0.01% 6981
2022
Q1
$1.01M Buy
103,578
+885
+0.9% +$8.61K ﹤0.01% 7667
2021
Q4
$996K Buy
102,693
+1,558
+2% +$15.1K ﹤0.01% 7969
2021
Q3
$981K Buy
+101,135
New +$977K ﹤0.01% 8207

Other funds holding MACA

Citadel Advisors's MACA Position: Q1 2023 in Review

Citadel Advisors sold out of Moringa Acquisition Corp Class A Ordinary Shares (MACA) in Q1 2023, closing a stake of 13,832 shares — an estimated $140K sold.

Citadel Advisors first reported a position in MACA in Q3 2021 and held it in 6 quarters. The position peaked at $1.03M in Q3 2022. 20 funds tracked by Wall St. Rank hold MACA as of Q1 2023.

  • Citadel Advisors reported no remaining Moringa Acquisition Corp Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 13,832 Moringa Acquisition Corp Class A Ordinary Shares shares in Q1 2023, an estimated $140K.
  • Citadel Advisors first reported a position in Moringa Acquisition Corp Class A Ordinary Shares in Q3 2021 and held it in 6 quarters.
  • Citadel Advisors's Moringa Acquisition Corp Class A Ordinary Shares position peaked at $1.03M in Q3 2022.
  • 20 funds tracked by Wall St. Rank held Moringa Acquisition Corp Class A Ordinary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.